Castlight Health, Inc. (NYSE:CSLT) Director Seth B. Cohen sold 30,000 shares of Castlight Health stock in a transaction dated Wednesday, June 9th. The stock was sold at an average price of $2.20, for a total value of $66,000.00. Following the sale, the director now owns 258,222 shares of the company’s stock, valued at approximately $568,088.40. The transaction was disclosed in a document filed with the SEC, which is available at this link.
CSLT opened at $1.98 on Friday. The stock has a market cap of $312.09 million, a PE ratio of -33.00 and a beta of 1.80. Castlight Health, Inc. has a 12 month low of $0.66 and a 12 month high of $2.36. The company has a 50-day simple moving average of $1.76.
Castlight Health (NYSE:CSLT) last released its quarterly earnings data on Thursday, April 29th. The software maker reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. The business had revenue of $35.06 million for the quarter. Castlight Health had a negative return on equity of 1.86% and a negative net margin of 6.20%. As a group, equities analysts predict that Castlight Health, Inc. will post -0.08 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Whetstone Capital Advisors LLC lifted its stake in shares of Castlight Health by 5.2% in the 4th quarter. Whetstone Capital Advisors LLC now owns 5,337,698 shares of the software maker’s stock valued at $6,939,000 after purchasing an additional 263,578 shares in the last quarter. Gagnon Securities LLC lifted its position in Castlight Health by 17.6% during the 1st quarter. Gagnon Securities LLC now owns 4,132,008 shares of the software maker’s stock worth $6,239,000 after acquiring an additional 618,193 shares in the last quarter. BlackRock Inc. lifted its position in Castlight Health by 5.0% during the 1st quarter. BlackRock Inc. now owns 3,191,093 shares of the software maker’s stock worth $4,818,000 after acquiring an additional 152,932 shares in the last quarter. Royce & Associates LP lifted its position in Castlight Health by 21.4% during the 1st quarter. Royce & Associates LP now owns 3,122,552 shares of the software maker’s stock worth $4,715,000 after acquiring an additional 551,092 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its position in Castlight Health by 18.1% during the 4th quarter. Renaissance Technologies LLC now owns 2,973,200 shares of the software maker’s stock worth $3,865,000 after acquiring an additional 455,996 shares in the last quarter. 55.03% of the stock is currently owned by institutional investors and hedge funds.
Castlight Health Company Profile
Castlight Health, Inc provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, government, and technology industries in the United States. It provides Care Guidance Navigator that enables users to make better care decisions and navigate the employer-sponsored healthcare benefit programs; Wellbeing Navigator, which helps to drive engagement across an employer's benefits program; Complete Health Navigator that combines the Wellbeing Navigator and Care Guidance Navigator packages for unified user experience; and Castlight Care Guides, a high-touch navigation service.
See Also: When is a capital gain realized?
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.